Finally A BIG THANK YOU to all my co-authors, they made this long journey started in 2021 a bit smoother! Thanks to Scaturro lab, Kohl lab, @brennanlab.bsky.social, @quangu.bsky.social, and Dundee proteomics! And of course thanks to the Tick cell Biobank and Lesley for those tiny cells!

Our strategy successfully identified two novel antiviral effectors: DHX9 and UPF1, both RNA helicases. While these proteins are known to participate in RNA detection and degradation, their precise mechanism of action against SFTSV remains unclear... Stay tuned for the next chapter! 🔍 #TickVirology

By integrating our omics layers, we generated a comprehensive snapshot of SFTSV infection. However, to identify factors crucial for SFTSV, biological validation was necessary. We performed knockdown of selected effectors in tick cells and tested their roles in SFTSV replication and infectivity.

Finally we finalized our omics characterization by looking at the interactors of SFTSV N protein during an active infection. N interactors were mostly related to stress, or RNA regulation pathways. We identified interactors conserved in human, and other associated with immune response to bunyavirus.

To understand our tick cell infection we focused on immune related pathways. We were able to map innate immune pathways (Jak-STAT, Toll, Imd). Interestingly little regulation was observed. Regulation was more important for stress-associated pathways suggesting a role in viral regulation.